九州大学 研究者情報
論文一覧
馬場 英司(ばばえいし) データ更新日:2019.03.07

教授 /  医学研究院 基礎医学部門 九州連携臨床腫瘍学講座(特定教育研究講座)


原著論文
1. Baba E, Fujishima H, Makiyama A, Uchino K, Tanaka R, Esaki T, Kusaba H, Mitsugi K, Nakano S, Akashi K,Phase II Study of Modified CPT-11 and Bolus 5-FU/l-Leucovorin in Japanese Metastatic Colorectal Cancer Patients.,Advances in Therapy,29,287-96,2012.03.
2. Isobe T, Baba E, Arita S, Komoda M, Tamura S, Shirakawa T, Ariyama H, Takaishi S, Kusaba H, Ueki T, Akashi K: ,Human STEAP3 maintains tumor growth under hypoferric condition.,Exp Cell Re,317,2582-91,2011.05.
3. Baba E, Esaki T, Ariyama H, Mitsugi K, Morikita T, Fujishima H, Kusaba H, Nakano S, Akashi K,Phase II study of sequential treatment with S-1 and cisplatin for metastatic gastric cancer,Cancer Chemother Pharmacol,68,611-7,2011.05.
4. Uchino K, Kusaba H, Kishimoto J, Mitsuyasu H, Kawasaki H, Baba E, Akashi K:,Validation of hospital anxiety and depression scale as a screening tool for psychological distress in advanced cancer patients undergoing chemotherapy.,Palliative Care Research,6,150-157,2011.12.
5. Baba E, Fujishima H, Makiyama A, Uchino K, Tanaka R, Esaki T, Kusaba H, Mitsugi K, Nakano S, Akashi K,Phase II Study of Modified CPT-11 and Bolus 5-FU/l-Leucovorin in Japanese Metastatic Colorectal Cancer Patients.,Advances in Therapy,29,287-96,2012.01.
6. Baba E, Esaki T, Ariyama H, Mitsugi K, Morikita T, Fujishima H, Kusaba H, Nakano S, Akashi K.,Phase II study of sequential treatment with S-1 and cisplatin for metastatic gastric cancer.,Cancer Chemother Pharmacol,2010.11.
7. Kusaba H, Esaki T, Futami K, Tanaka S, Fujishima H, Mitsugi K, Sakai K, Ariyama H, Tanaka R, Kinugawa N, Ueki T, Mibu R, Baba E, Nakano S, Akashi K.,Phase I/II study of a 3-week cycle of irinotecan and S-1 in patients with advanced colorectal cancer.,Cancer Sci,101,2591,2010.12.
8. Shibata Y, Ariyama H, Baba E, Takii Y, Esaki T, Mitsugi K, Tsuchiya T, Kusaba H, Akashi K, Nakano S,Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan,Int J Clin Oncol,2009 in Press,2009.12.
9. Baba E, Fujishima H, Kusaba H, Esaki T, Ariyama H, Kato K, Tanaka R, Mitsugi K, Shibata Y, Harada M, Nakano S,Phase I Study of the Sequential Administration of S-1 and Cisplatin for Metastatic Gastric Cancer,Anticancer Res,29(5), 1727-32, 2009,2009.06.
10. Makiyama A, Qin B, Uchino K, Shibata Y, Arita S, Isobe T, Hirano G, Kusaba H, Baba E, Akashi K, Nakano S,Schedule-dependent synergistic interaction between gemcitabine and oxaliplatin in human gallbladder adenocarcinoma cell lines,Anticancer Drugs,20(2),123-30,2009,2009.02.
11. Tabrizi SJ, Niiro H, Masui M, Yoshimoto G, Iino T, Kikushige Y, Wakasaki T, Baba E, Shimoda S, Miyamoto T, Hara T, Akashi K,T cell leukemia/lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins,J Immunol 182(3): 1490-1499, 2009,2009.02.
12. Arita S, Baba E, Shibata Y, Niiro H, Shimoda S, Isobe T, Kusaba H, Nakano S, Harada M,B cell activation regulates exosomal HLA production,Eur J Immunol ,38(5): 1423-1434, 2008,2008.06.
13. Kanda Y, Omuro Y, Baba E, Oshima K, Nagafuji K, Heike Y, Takaue Y, Sasaki T, Sakamaki H, Harada M,Allo-SCT using reduced-intensity conditioning against advanced pancreatic cancer: a Japanese survey,Bone Marrow Transplant ,42(2): 99-103, 2008,2008.06.
14. Tomiyama N, Higashiuesato Y, Oda T, Baba E, Harada M, Azuma M, Yamashita T, Uehara K, Miyazato A, Hatta K, Ohya Y, Iseki K, Jinno Y, Takishita S,MEFV mutation analysis of familial Mediterranean fever in Japan,Clin Exp Rheumatol ,26(1): 13-17, 2008,2008.06.
15. Ariyama H, Qin B, Baba E, Tanaka R, Mitsugi K, Harada M, Nakano S. ,Gefitinib, a selective EGFR tyrosine kinase inhibitor, induces apoptosis through activation of Bax in human gallbladder adenocarcinoma cells. ,J Cell Biochem,97:724-34,2006.12.
16. Baoli Q, Kato K, Mitsugi K, Nakamura M, Tanaka R, Baba E, Ariyama H, Kuroiwa T, Harada M, Nakano S,Baoli Q, Kato K, Mitsugi K, Nakamura M, Tanaka R, Baba E, Ariyama H, Kuroiwa T, Harada M, Nakano S. Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer. ,. Cancer Chemother Pharmacol. ,57(1):114-119,2006.01.
17. Morisaki T, Matsumoto K, Kuroki H, Kubo M, Baba E, Onishi H, Tasaki A, Nakamura M, Inaba S, Katano M.,Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.,Anticancer Res.,23(6a):4459-65.,2003.11.
18. Tasaki A, Yamanaka N, Kubo M, Matsumoto K, Kuroki H, Nakamura K, Nakahara C, Onishi H, Kuga H, Baba E, Tanaka M, Morisaki T, Katano M.,Three-dimensional two-layer collagen matrix gel culture model for evaluating complex biological functions of monocyte-derived dendritic cells.,J Immunol Methods.,287(1-2):79-90.,2004.04.
19. Fujishima H, Kikuchi I, Miyanaga O, Ueda A, Baba E, Mitsugi K, Harada M, Nakano S.,Phase I study of CPT-11 and bolus 5-FU/ l-leucovorin in patients with metastatic colorectal cancer.,Int J Clin Oncol.,9(2):92-7.,2004.04.
20. Mitsugi K, Nakamura T, Kashiwabara N, Ariyama H, Tanaka R, Baba E, Nakamura M, Harada M, Nakano S.,Protection against methotrexate toxicity by a soybean protein- and omega-3 fatty acid-containing diet: comparative study with a casein-containing diet.,Oncol Rep.,12(1):41-5.,2004.07.
21. Onishi H, Kuroki H, Matsumoto K, Baba E, Sasaki N, Kuga H, Tanaka M, Katano M, Morisaki T.,Monocyte-derived dendritic cells that capture dead tumor cells secrete IL-12 and TNF-alpha through IL-12/TNF-alpha/NF-kappaB autocrine loop,Cancer Immunol Immunother.,2004.06.

九大関連コンテンツ

pure2017年10月2日から、「九州大学研究者情報」を補完するデータベースとして、Elsevier社の「Pure」による研究業績の公開を開始しました。
 
 
九州大学知的財産本部「九州大学Seeds集」